Levocabastine: Pharmacological profile of a highly effective inhibitor of allergic reactions

This publication has 9 references indexed in Scilit:

• Effects of topical treatment with H₁ and H₂ antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis
  Allergy, 1989
• PHARMACOLOGY OF RISPERIDONE (R 64 766), A NEW ANTIPSYCHOTIC WITH SEROTONIN-S2 AND DOPAMINE-D2 ANTAGONISTIC PROPERTIES
  1988
• Drug‐receptor dissociation time, new tool for drug research: Receptor binding affinity and drug‐receptor dissociation profiles of serotonin‐S₂, Dopamine‐D₂, histamine‐H₁ antagonists, and opiates
  Drug Development Research, 1986
• Oral antiallergic activity in ascaris hypersensitive dogs: A study of known antihistamines and of the new compounds ramastine (R 57 959) and levocabastine (R 50 547)
  Drug Development Research, 1986
• Levocabastine (R 50547): The prototype of a chemical series of compounds with specific H₁‐antihistaminic activity
  Drug Development Research, 1986
• Chemical development of astemizole‐like compounds
  Drug Development Research, 1986
• Interaction of astemizole and other drugs with passive cutaneous anaphylactic and histamine‐, serotonin‐, and compound 48/80‐induced skin reactions in the rat: A Procedure to determine anti‐allergic effectiveness
  Drug Development Research, 1985
• Inhibitors of mast cell-mediated shock in the rat: Relationship to histamine and serotonin antagonism
  Drug Development Research, 1981
• PROTECTION OF RATS FROM COMPOUND 48-80-INDUCED LETHALITY - SIMPLE TEST FOR INHIBITORS OF MAST CELL-MEDIATED SHOCK
  1978